Report Descriptions:

The Global Veterinary Infectious Disease Diagnostics Market was estimated at USD 2.64 billion in 2026 and is projected to reach USD 6.57 billion by 2035, reflecting a robust CAGR of 9.55% over the forecast period from 2026 to 2035. The Veterinary Infectious Disease Diagnostics market report offers a comprehensive and nuanced view of the industry, moving beyond conventional analysis. It provides a thorough examination of the markets dynamics, encompassing a detailed exploration of the factors propelling growth, such as evolving economic conditions, advancements in technology, shifts in regulatory policies, and changes in consumer behavior. Furthermore, the report discusses the projected Compound Annual Growth Rate (CAGR), providing stakeholders with a clear understanding of the market's expected growth trajectory and offering data-driven insights into future market dynamics.

The Veterinary Infectious Disease Diagnostics market under analysis is characterized by dynamic growth and evolving trends that are reshaping the competitive landscape. With 2025 serving as the base year for this Veterinary Infectious Disease Diagnostics market study, recent data highlights a significant expansion driven by technological advancements, rising consumer demand, and a growing focus on innovation. Companies are refining their go-to-market (GTM) strategies to effectively capture these emerging opportunities and respond to the rapidly changing market dynamics.

Key trends influencing the Veterinary Infectious Disease Diagnostics market include the rapid adoption of digital technologies, the integration of sustainable practices, and the increasing importance of customer experience. These trends are not only driving growth but also creating new challenges for industry participants, who must adapt their GTM strategies to navigate regulatory changes, supply chain disruptions, and fluctuating economic conditions. Despite these challenges, the Veterinary Infectious Disease Diagnostics market is poised for sustained growth, with emerging markets playing a critical role in the expansion of the industry.

Looking ahead, the Veterinary Infectious Disease Diagnostics market is forecasted to continue its upward momentum through 2035, supported by ongoing investments in research and development, strategic partnerships, and mergers and acquisitions. Companies that can effectively tailor their GTM strategies to the evolving market landscape, innovate, and meet shifting consumer demands are likely to achieve sustained success. Veterinary Infectious Disease Diagnostics market report provides a comprehensive analysis of the current market environment and offers valuable insights into the key drivers, challenges, and opportunities that will shape the industry's future over the next decade. This report offers a comprehensive analysis of market dynamics across various segments, regions, and countries, incorporating both qualitative and quantitative data. It covers the period from 2017 to 2035, providing a detailed examination of historical performance, current market conditions, and future projections.

Historical Analysis (2017-2024): The report presents a thorough review of market trends, performance metrics, and growth trajectories for the years 2017 through 2024. This historical perspective is crucial for understanding past market behavior and identifying patterns that influence current and future market dynamics.

Forecast and Projections (2026-2035) : Building on historical data, the report provides forward-looking insights, including market forecasts and growth projections from 2026 to 2035. It details anticipated market trends, emerging opportunities, and potential challenges across different segments, regions, and countries.

Compound Annual Growth Rate (CAGR): The report includes a precise calculation of the compound annual growth rate (CAGR) for the forecast period of 2026 to 2035. This metric will be instrumental in assessing the expected growth trajectory and the overall market potential during the forecast period.

Veterinary Infectious Disease Diagnostics Market

Veterinary Infectious Disease Diagnostics Market

The Veterinary Infectious Disease Diagnostics Market refers to the global and regional market for diagnostic tools, technologies, and services used to detect, monitor, and manage infectious diseases in animals. This includes companion animals (e.g., dogs, cats), livestock (e.g., cattle, poultry, swine), and wildlife. The market covers a range of diagnostic modalities such as immunodiagnostics (e.g., ELISA, lateral flow assays), molecular diagnostics (e.g., PCR, RT-PCR), microbiology, and clinical pathology, aimed at identifying bacterial, viral, fungal, and parasitic infections.

These diagnostics play a critical role in early disease detection, outbreak control, treatment planning, herd health monitoring, and compliance with international trade and food safety regulations. Commonly targeted infectious diseases include rabies, avian influenza, bovine tuberculosis, brucellosis, foot-and-mouth disease (FMD), leptospirosis, and feline leukemia virus (FeLV), among others.

What are the drivers of the veterinary Infectious disease diagnostics market

• More cases of avian influenza, foot-and-mouth disease and canine parvovirus driven by more pets and more intensive farming are driving the need for accurate, fast diagnostics to control outbreaks and economic losses.
• Innovations in molecular diagnostics (PCR, multiplex assays), immunodiagnostics and POC devices enable on-site, fast and precise disease detection. These are critical in rural or emergency situations where lab access is limited.
• Pet owners, farmers and veterinarians are getting more concerned about animal welfare and zoonotic disease risk and are driving proactive disease screening and surveillance including One Health programs.
• Public health agencies (e.g. USDA, OIE/WOAH) are funding diagnostics infrastructure, outbreak prevention, and standardisation is driving market uptake and cross-border harmonisation.
• More pets and more farming globally, more veterinary spending and better lab capabilities are driving the routine use of infectious disease diagnostics.

What are the challenges and restraining factors of the veterinary Infectious disease diagnostics market

• Next generation sequencing technologies (e.g. PCR, ELISA) are expensive and require specialized facilities and staff for operation. These high costs can prohibit use in small animal practices, particularly in low-resource areas.
• The veterinary diagnostic system is often underdeveloped in isolated and low-income areas. This can cause delays in diagnosis and treatment, furthering disease spread and reducing diagnostic demand.
• Diagnostic tests and protocols vary by region and species. There is currently a lack of harmonisation in testing standards, which can lead to inconsistent test results, misdiagnosis, or underreporting of outbreaks.

What are the regional trends of the veterinary Infectious disease diagnostics market

• North America dominates the veterinary Infectious disease diagnostics market because of its progressive infrastructure, sophisticated diagnostic equipment, and governmental assistance. The USDA's National Animal Health Laboratory Network (NAHLN) is an important component in pathogen surveillance and outbreak response (e.g., avian flu, FMD). The region boasts a large pet-owning population and increasing veterinary expenditure, driving adoption of cutting-edge molecular and immunodiagnostic technology.
• Europe's strong "One Health" philosophy, promoted by WOAH's regional commissions and EU-coordinated action, underpins the European veterinary diagnostic market. Institutional players such as the UK's Pirbright Institute fund disease surveillance and control in livestock (e.g., bovine TB) under government auspices. Increased pet ownership and enforced zoonotic controls, combined with long-standing insurance schemes, are driving increasing demand for periodic infectious disease screening.
• Asia Pacific fastest-growing region, driven by urbanisation, rising companion animal ownership, and the expansion of livestock industries. WHO and FAO One Health initiatives increasingly integrate veterinary diagnostics into zoonotic surveillance.
• Latin Americas market is growing steadily, bolstered by expanding livestock farming and urban pet ownership. The Pan American Health Organisation (PAHO) supports efforts in zoonotic disease control, enhancing diagnostic availability. National outbreaks such as avian influenza in Brazil highlight the need for swift diagnostic capabilities. Argentina is noted for its rapid adoption of molecular diagnostics in the livestock sector.
• Middle East and Africa show emerging diagnostic growth, especially across the Gulf Cooperation Council (GCC) countries. WHOs EMRO office prioritises zoonotic preparedness in region-specific health planning. In Africa, institutes like Nigerias NVRI work on livestock disease detection (e.g., FMD, avian influenza) under government and FAO-supported networks.

Country-Wise Outlook:

• United States National Network & Public Investment: The veterinary Infectious disease diagnostics market is dominated by the United States because of strict environmental regulations and a great amount of beverage consumption. Large beverage companies such as Coca-Cola and PepsiCo have taken up environmentally friendly product packaging, trying to stem the onslaught of Extended Production Responsibility (EPR) policies and consumer-based activism. The market in the U.S consists of fast innovation of biodegradable/photodegradable material of ring components, which include PHA or post-consumer recycled plastics. The leading states in the ban on plastic rings include California and Oregon, which increases demand for the adoption of green alternatives. There is increased popularity of technologies such as injection-moulded HDPE rings and compostable fibre-based carriers. Still, the cooperation between the beverage giants and packaging start-ups even more boosts the transformation of the market.
• Germany One Health Integration & Centralised Surveillance: Germany uses its national Friedrich-Loeffler-Institute (FLI), the federal animal health institute, to conduct high-level diagnostics and reference testing for avian influenza and foot-and-mouth disease on a national and EU-regulated basis. Internally, the Animal Diseases Information System (ADIS) at the EU level integrates member states' real-time information in standardized format to facilitate quick response to outbreaks. These centralized systems support an integrated One Health platform, enabling seamless cross-border surveillance of diseases and animal health management that is trade-safe.
• Japan Modern Veterinary Systems & Regional Disease Preparedness: Japan has built a robust network of laboratory infrastructures for veterinary diagnosis, and national veterinary institutes and university laboratories are well integrated into animal disease surveillance systems. Robust support from governments through institutions such as the Ministry of Agriculture and international coordination with the WHO and the FAO facilitates both zoonotic and livestock disease surveillance. Field-level diagnostic information, while less centralised in the public sector, is regularly upgraded by Japan and promotes rapid-response diagnostic capability to combat evolving veterinary pathogens.

Competitive Analysis:

The veterinary diagnostic industry is highly concentrated, with major competitors like IDEXX Laboratories, Zoetis, Thermo Fisher Scientific, Heska, and Neogen. These companies compete geographically and through product development, acquisitions, and strategic alliances to improve their diagnostic offerings.

New advancements in molecular diagnostics (PCR, next-generation sequencing) and point-of-care immunoassays are reshaping market competition. Industry-wide shifts focus on rapid, on-farm testing platforms and multiplex assays for zoonotic agents. For instance, AI-enabled diagnostic tools and in-house molecular systems are gaining traction in veterinary clinics and mobile orders. Additionally, high-throughput labs are incorporating automation and digital pathology services to streamline workflows and respond to increasing disease surveillance demands.

Price continues to be a potent weapon of competition, particularly in large-volume livestock testing and typical companion animal testing. Veterinary clinics, producers, and lab facilities prefer bundled service agreements and bulk rates. Low-cost rapid kits and new market entrants are driving prices down, demanding cost-effective innovation at the cost of nothing more than accuracy.

Sellers are setting up local laboratories, entering into local distribution partnerships, and conforming to local laws via partnerships with institutions of government and institutions of One Health.

Strategic institutional arrangements and technology collaborations expand diagnostic capability. highlight public investment's potential for assisting in the development of surge capacity, training the workforce, and piloting initiatives. Mutual arrangements such as CRADAs and the Federal Technology Transfer Act (FTTA) enable partnership between industry and laboratories for the creation of new diagnostic methods. The partnership enables companies to utilise advanced licensing and scaling strategies within controlled environments.

Key Players

IDEXX Laboratories, Zoetis, Thermo Fisher Scientific, Bio-Rad Laboratories, Virbac, Neogen Corporation, Heska Corporation, Agrolabo, BioChek, IDvet, GD Animal Health, Bionote, INDICAL BIOSCIENCE, VMRD Inc., and MegaCor Diagnostik.

Recent Development:

• In June 2025, Assam Agricultural University College of Veterinary Science and GeNext Genomics launched a quick antigen test kit with the capability to detect African Swine Fever (ASF) in minutesa grassroots diagnostic innovation. This is being followed by a future portable "Lab-in-a-Suitcase" capable of diagnosing several swine diseases with power independence built into it. The project was supported by India's Department of Biotechnology and has WHO One Health objectives for zoonotic and animal disease control.
• In February 2024, MiDOG Animal Diagnostics introduced a groundbreaking multiplex molecular test for detecting bacterial and fungal infections, including antibiotic resistance, in one test in multiple animal species. The combined solution accelerates disease identification, driving more precise treatment paths and being one step closer to complete-point-of-care molecular diagnostics.
• In January 2024, IDEXX Laboratories unveiled a highly advanced artificial intelligence-based diagnostic platform to raise accuracy and efficiency in companion animal infection diagnosis. The platform facilitates quick test interpretation and evidence-based decision-making, highlighting diagnostic ingenuity amidst burgeoning adoption of artificial intelligence.

Study Period for the Veterinary Infectious Disease Diagnostics Market:

Veterinary Infectious Disease Diagnostics Market

Report Highlights:

Our team of experienced researchers has meticulously gathered and analyzed data to deliver a thorough examination of market dynamics, competitive landscape, and emerging technologies. With a focus on delivering actionable intelligence, this report aims to empower decision-makers with the information needed to make informed choices and stay ahead of the competition. Whether you are a seasoned industry player or a new entrant, our market research report serves as a strategic tool to navigate the complexities of the market, aiding in successful business planning and growth strategies.

Key Chapters of our Veterinary Infectious Disease Diagnostics Market Report includes:

Market Dynamics, Variables, and Industry Analysis:

This chapter of our Veterinary Infectious Disease Diagnostics market report provides an in-depth examination of the factors shaping the industry landscape. This section typically encompasses several key elements to offer a comprehensive understanding of the industry landscape such as market drivers & restraints analysis, market opportunities & trend analysis, market size & growth analysis, competitive analysis, SWOT analysis, business environment tools such as Porter's five forces & PESTEL analysis, Ansoff Matrix analysis, penetration & growth prospect analysis, regulatory framework & reimbursement scenario analysis, impact of macro & micro economic factors analysis such as Covid-19 impact, GDP growth, market inflation, U.S.- China trade war, Russia-Ukraine war impact, and supply chain analysis.

Segment Analysis & Forecast to 2035:

The segment analysis chapter of Veterinary Infectious Disease Diagnostics market report is a critical section that delves into a detailed examination of the market's various segments. Segmentation involves dividing the market into distinct categories based on certain criteria to better understand and address the diverse needs of consumers. This chapter typically follows the introduction and provides a more granular view of the market, offering valuable insights for businesses and stakeholders. The components of the chapter lude segment definitions to understand the inclusions and exclusions of the study, assumptions, market size estimates and growth trend analysis of each segment, qualitative analysis of the segment, technological advancements, market penetration rate, market adoption rate, market share examination by each segment, segment growth drivers and restraint barriers, consumer behaviour and challenge analysis.

Regional Market Analysis & Forecast to 2035:

The chapter in Veterinary Infectious Disease Diagnostics market research report is a pivotal section that examines and predicts the market dynamics and trends specific to different geographical regions. This chapter is crucial for businesses and stakeholders seeking a comprehensive understanding of how the market behaves across various locations, enabling them to tailor strategies and make informed decisions based on regional variations. The regional analysis chapter of our Veterinary Infectious Disease Diagnostics market report is classified into regions & country-level. The chapter consists of North America (U.S., Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Sweden, Denmark, Norway, Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, Thailand, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Colombia, Rest of Latin America), Middle East & Africa (South Africa, Saudi Arabia, UAE, Kuwait, Rest of Middle East & Africa).

Veterinary Infectious Disease Diagnostics Market

Competitive Analysis & Company Profiles:

This section of a Veterinary Infectious Disease Diagnostics market report is a crucial segment that provides a comprehensive overview of the competitive landscape within the market. This section is vital for businesses, investors, and stakeholders seeking insights into key players, their market positioning, strengths, weaknesses, strategies, and potential impacts on the overall market dynamics. The chapter includes research methodology used to analyse the market competition, list of key players operating in the market, detailed company profile section which includes company overview, business verticals, financial performance, product/services benchmarking, geographical presence, and strategic initiatives.

Key Players Operating in the Veterinary Infectious Disease Diagnostics Market are as follows:

• IDEXX Laboratories, Zoetis, Thermo Fisher Scientific, Bio-Rad Laboratories, Virbac, Neogen Corporation, Heska Corporation, Agrolabo, BioChek, IDvet, GD Animal Health, Bionote, INDICAL BIOSCIENCE, VMRD Inc., MegaCor Diagnostik.

Veterinary Infectious Disease Diagnostics Market

Report Scope:

Quintile Reports has segmented the Veterinary Infectious Disease Diagnostics market into the following segments:

Based on Product, the Veterinary Infectious Disease Diagnostics market is segmented into:

• Consumables
• Reagents & Kits
• Equipment & Instruments

Based on Technology, the Veterinary Infectious Disease Diagnostics market is segmented into:

• Immunodiagnostics (Lateral Flow Assays
• ELISA Test
• Others)
• Molecular Diagnostics (Polymerase Chain Reaction (PCR) Tests
• Microarrays
• Others)
• Others

Based on Animal, the Veterinary Infectious Disease Diagnostics market is segmented into:

• Livestock (Poultry
• Cattle
• Swine
• Others)
• Companion (Canine
• Feline
• Equine
• Others)

Based on Infection, the Veterinary Infectious Disease Diagnostics market is segmented into:

• Bacterial
• Viral
• Parasitic
• Others

Based on End Use, the Veterinary Infectious Disease Diagnostics market is segmented into:

• Veterinary Hospitals and Clinics
• Veterinary Reference Laboratories
• Others

Report Scope	Details
Report Version	2026
Growth Rate	CAGR of 9.55 from 2026 to 2035
Base year	2025
Actual estimates/Historical data	2017 - 2024
Forecast period	2026 - 2035
Quantitative units	Revenue in USD million/billion & CAGR from 2026 to 2035
Country scope	North America (U.S., Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Sweden, Denmark, Norway, Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, Thailand, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Colombia, Rest of Latin America), Middle East & Africa (South Africa, Saudi Arabia, UAE, Kuwait, Rest of Middle East & Africa).
The Segment covered by Product	Consumables Reagents & Kits Equipment & Instruments
The Segment covered by Technology	Immunodiagnostics (Lateral Flow Assays ELISA Test Others) Molecular Diagnostics (Polymerase Chain Reaction (PCR) Tests Microarrays Others) Others
Companies covered	IDEXX Laboratories, Zoetis, Thermo Fisher Scientific, Bio-Rad Laboratories, Virbac, Neogen Corporation, Heska Corporation, Agrolabo, BioChek, IDvet, GD Animal Health, Bionote, INDICAL BIOSCIENCE, VMRD Inc., MegaCor Diagnostik.
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Free customization scope (equivalent to 5 analyst working days)	If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of the customization

Key Reasons to Acquire the Veterinary Infectious Disease Diagnostics Market Research Report:

• This report offers a comprehensive analysis of the Veterinary Infectious Disease Diagnostics market from 2017 to 2035, including market segments, current trends, estimations, and dynamics
• It also provides information on key drivers, restraints, and opportunities
• Porter's five forces analysis is used to assess the potency of buyers and suppliers, helping stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network
• The report includes an in-depth analysis of the Veterinary Infectious Disease Diagnostics market segmentation to identify prevailing market opportunities
• Major countries in each region are mapped according to their revenue contribution to the global market
• Market player positioning is also analyzed to facilitate benchmarking and provide a clear understanding of the present position of the market players
• The report includes an analysis of the regional and global Veterinary Infectious Disease Diagnostics market trends, key players, market segments, application areas, and market growth strategies

Veterinary Infectious Disease Diagnostics Market

Available Customizations:

With the given market data, Quintile Reports offers customizations according to the company's specific needs. The following customization options are available for the report:

• You may ask for a global, regional, or country-specific report.
• You may ask if there are any particular types, applications, or products on which you would like to focus.
• You may ask for specific competitors/players to be profiled.

Veterinary Infectious Disease Diagnostics Market Report

Statistics for the 2025 Veterinary Infectious Disease Diagnostics market share, size, and revenue growth rate were created by Quintile Report™. Veterinary Infectious Disease Diagnostics analysis includes a market forecast outlook for 2035 and a historical overview. Get a free PDF sample of this market analysis, please get in touch with our principal analyst at sales@quintilereports.com